Comparative study of efficacy and safety of Yahom-Navakot remedy plus Levofloxacin vs Levofloxacin alone in prevention of nosocomial infection in post-cardiac arrest patients treated by targeted temperature management: A randomized, double blinded, placebo controlled trial
Phase 4
- Conditions
- Post-Cardiac Arrest PatientsTargeted Temperature Management, Nosocomial Infection,Levofloxacin, Yahom-Navakot remedy and Post-cardiac arrest
- Registration Number
- TCTR20200430004
- Lead Sponsor
- Thammasat University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- nknown
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1.Ventricular fibrillation or pulseless ventricular tachycardia
2. Witnessed arrest
3. Glassgow Coma scale(GCS) < 8
4. Systolic Blood Pressure > 90 mmHg
5. Receive Targeted Temperature Management
6. Male and female with age 20-90 year old
Exclusion Criteria
1. Known allergy to Yahom-Navakot remedy or levofloxacin
2. Terminal illness
3. Pregnancy and lactation
4. Known infection with antibiotic usage within 1 week
5. abnormal clotting with unable to recovery
6. GI bleeding
7. unable to have NG-tube feeding or GI malabsorption
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method